These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37189167)

  • 1. Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity.
    Cascianelli S; Barbera C; Ulla AA; Grassi E; Lupo B; Pasini D; Bertotti A; Trusolino L; Medico E; Isella C; Masseroli M
    Genome Med; 2023 May; 15(1):37. PubMed ID: 37189167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
    Isella C; Brundu F; Bellomo SE; Galimi F; Zanella E; Porporato R; Petti C; Fiori A; Orzan F; Senetta R; Boccaccio C; Ficarra E; Marchionni L; Trusolino L; Medico E; Bertotti A
    Nat Commun; 2017 May; 8():15107. PubMed ID: 28561063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
    Alderdice M; Richman SD; Gollins S; Stewart JP; Hurt C; Adams R; McCorry AM; Roddy AC; Vimalachandran D; Isella C; Medico E; Maughan T; McArt DG; Lawler M; Dunne PD
    J Pathol; 2018 May; 245(1):19-28. PubMed ID: 29412457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
    PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
    Quinn GP; Sessler T; Ahmaderaghi B; Lambe S; VanSteenhouse H; Lawler M; Wappett M; Seligmann B; Longley DB; McDade SS
    BMC Bioinformatics; 2022 Mar; 23(1):114. PubMed ID: 35361119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients.
    van de Weerd S; Smit MA; Roelands J; Mesker WE; Bedognetti D; Kuppen PJK; Putter H; Tollenaar RAEM; Roodhart JML; Hendrickx W; Medema JP; van Krieken JHJM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
    Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
    Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathological classification of colorectal cancer-an update.
    Dunne PD; Arends MJ
    Virchows Arch; 2024 Feb; 484(2):273-285. PubMed ID: 38319359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy.
    Allen WL; Dunne PD; McDade S; Scanlon E; Loughrey M; Coleman H; McCann C; McLaughlin K; Nemeth Z; Syed N; Jithesh P; Arthur K; Wilson R; Coyle V; McArt D; Murray GI; Samuel L; Nuciforo P; Jimenez J; Argiles G; Dienstmann R; Tabernero J; Messerini L; Nobili S; Mini E; Sheahan K; Ryan E; Johnston PG; Van Schaeybroeck S; Lawler M; Longley DB
    JCO Precis Oncol; 2018 Jun; 2018():. PubMed ID: 30088816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Sirinukunwattana K; Domingo E; Richman SD; Redmond KL; Blake A; Verrill C; Leedham SJ; Chatzipli A; Hardy C; Whalley CM; Wu CH; Beggs AD; McDermott U; Dunne PD; Meade A; Walker SM; Murray GI; Samuel L; Seymour M; Tomlinson I; Quirke P; Maughan T; Rittscher J; Koelzer VH;
    Gut; 2021 Mar; 70(3):544-554. PubMed ID: 32690604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges.
    Dang Q; Zuo L; Hu X; Zhou Z; Chen S; Liu S; Ba Y; Zuo A; Xu H; Weng S; Zhang Y; Luo P; Cheng Q; Liu Z; Han X
    Cancer Med; 2024 Jul; 13(14):e70041. PubMed ID: 39054866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.
    Linnekamp JF; Hooff SRV; Prasetyanti PR; Kandimalla R; Buikhuisen JY; Fessler E; Ramesh P; Lee KAST; Bochove GGW; de Jong JH; Cameron K; Leersum RV; Rodermond HM; Franitza M; Nürnberg P; Mangiapane LR; Wang X; Clevers H; Vermeulen L; Stassi G; Medema JP
    Cell Death Differ; 2018 Mar; 25(3):616-633. PubMed ID: 29305587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.
    Bramsen JB; Rasmussen MH; Ongen H; Mattesen TB; Ørntoft MW; Árnadóttir SS; Sandoval J; Laguna T; Vang S; Øster B; Lamy P; Madsen MR; Laurberg S; Esteller M; Dermitzakis ET; Ørntoft TF; Andersen CL
    Cell Rep; 2017 May; 19(6):1268-1280. PubMed ID: 28494874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.
    Adam RS; Poel D; Ferreira Moreno L; Spronck JMA; de Back TR; Torang A; Gomez Barila PM; Ten Hoorn S; Markowetz F; Wang X; Verheul HMW; Buffart TE; Vermeulen L
    Mol Oncol; 2022 Jul; 16(14):2693-2709. PubMed ID: 35298091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with mesenchymal tumours and high
    Salvucci M; Crawford N; Stott K; Bullman S; Longley DB; Prehn JHM
    Gut; 2022 Aug; 71(8):1600-1612. PubMed ID: 34497144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content.
    Miller SA; Ghobashi AH; O'Hagan HM
    Cancer Genet; 2021 Jun; 254-255():34-39. PubMed ID: 33571895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification.
    Dunne PD; Alderdice M; O'Reilly PG; Roddy AC; McCorry AMB; Richman S; Maughan T; McDade SS; Johnston PG; Longley DB; Kay E; McArt DG; Lawler M
    Nat Commun; 2017 May; 8():15657. PubMed ID: 28561046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.